Introduction
Flos Lonicerae, also called Jinyinhua, is one of the widely used herbs prescribed in many Chinese formulas owing to its antibiotic property [1, 2] . The main active ingredient is chlorogenic acid ( Figure 1A ). It has latent-heat-clearing, antipyretic, detoxicant and anti-inflammatory actions [3, 4] . It has been, therefore, prescribed to treat fever due to common cold, febrile disease, dysentery, carbuncles, and virulent swellings, and great progress has been made in the studies and clinical applications of Flos Lonicerae in the last couple of years [5] .Trimethoprim is a folic acid antagonist, inhibits dihydrofolate reductase enzyme, which catalyses the conversion of dihydrofolate to tetrahydrofolic acid (Figure 1B) , and this affects the biosynthesis of DNA [6] . This drug has been used clinically for the treatment of bacterial infections, including gastro and respiratory tract infections, in particular the common urinary tract infections [7] .Although Flos Lonicerae and Trimethoprim have been extensively studied for many years, no investigation on the bactericidal activity of Trimethoprim-Flos Lonicerae has been reported so far. Herein the main purpose of the present study was to evaluate the synergistic effect and dose-effect relationship of Trimethoprim on bactericidal activity of Flos Lonicerae in vitro.
Materials and Methods

Microorganisms
Bacterial strains used in this research are Staphylococcus aureus ACTT 25923，Escherichia coli ATCC 35218 and Salmonella ATCC 50115 were obtained from the Institude of Microbiology Chinese Academy of Sciences. They were also employed as test organisms. Stock cultures were maintained at 4℃ on slopes of nutrient agar. The cultures were diluted to achieve optical densities corresponding to 1.0×10 7 colony forming units (cfu/ml) for bacterial strains.
Herb Extraction
Flos Lonicerae were purchased from Furuibang Medicine Limited Company (Daqing, China); the quality of the herb extract was controlled according to the requirements of Pharmacopoeia of the People's Republic of China. Trimethoprim was purchased from Kangruibao Medicine Limited Company (Taiyuan, China). The raw powder of Flos Lonicerae were dried at 50℃ to constant weight. Approximately 10g of pulverized sample (equivalently to 100g crude drug) was added into an empty beaker with 100ml distilled water and 400ml dehydrated alcohol being poured respectively with constantly stir. The mixture was stored at 4℃ for 24h followed by centrifugation at 4000rpm for 30min. The supernatant fraction was filtered with 0.45μm of filter membrane and pooled. The extracts were combined, concentrated and evaporated to dryness with rotary evaporator under reduced pressure. The ethanol was filtered and evaporated at 50℃. The residue was dissolved with 50ml of distilled water into a 100ml beaker. This solution was regarded as a concentration of 200% (50ml of HC solution made from 100g of raw material). After being autoclaved at 100℃ for 20min, the stock solution was stored at 4℃. Antimicrobial susceptibility testing Broth micro-dilution assay method and turbidimetric method was conducted to determine the antimicrobial susceptibility MIC of TMP and Flos Lonicerae against bacteria separately [6] . With sterile round-bottom 96-well plates, duplicate two-fold serial dilutions of extract (100μl per well) were prepared in the appropriate broth to produce a concentration range of 2000 to 15.6mg/ml of extracts. A bacterial cell suspension (prepared in the appropriate broth) of 100μl, corresponding to 1×10 6 cfu/ml, was added in all wells except those in 3 columns which served as saline, extract and media sterility controls, respectively. Controls for bacterial growth without Flos Lonicerae extracts were also included on each plate. The final concentration of bacteria in the assay was 5×10 5 cfu/ml. The final concentration of extracts ranged between 1000 to 7.8mg/ml. MIC of every extract was determined as the lowest concentration at which no bacterial growth was observed in the duplicate well after plates were then incubated at 37℃ for 18h. Every test was performed in triplicate. Minimum bactericidal concentration (MBC) was determined by plating aliquots from those wells with no bacterial growth onto MH agar plates. MBC was defined as the lowest concentration of the extracts causing a 99.9% loss of viability with respect to the cfu/ml inoculated. Evaluation of synergy effect Checkerboard assay was conducted to evaluate the synergy effect of Trimethoprim on bactericidal activity of Flos Lonicerae gainst Staphylococcus aureus, Escherichia coli and Salmonella separately in vitro. Checkerboard titration is one of the most frequently used techniques to access drug interactions. Test was performed utilizing 96 well microtiter plates. MICs were determined for every medicine by broth microdilution according to standards of the CLSI (Clinical Laboratory Standardization Institute). Each combination assay was performed at triplicates. Synergism by the checkerboard method was defined as an FIC index of ≤ 0.5, additive effect was defined as an FIC index of > 0.5 and ≤ 1, Indifference effect was defined as an FIC index of > 1 and ≤ 2 and antagonism effect was defined as an FIC index of > 4. Concentrations within the FIC panel were such that the MIC of each antibiotic was in the middle of the range of concentrations tested.
The FIC indices for all combinations were calculated using the formula below:
The FIC for a drug in a given well is derived by dividing the drug concentration in the given well by the control MIC of the test organism to that drug.
The FIC index for a well is the sum of the FICs for each of the drugs present in the well: FIC index = FIC A +FIC B Time-kill plot Dose-effect relationship determinations were performed using two-fold dilution and plate count methods. The broth dilution assay was based on that recommended by the National Committee for Clinical Laboratory Standards. A series of twofold dilutions of each agent were prepared in medium broth. Trimethoprim was diluted to 640μg/ml, 320μg/ml, 160μg/ml, 80μg/ml and 40μg/ml. Flos Lonicerae was diluted to 2×MIC. The inoculum was prepared from a fresh broth culture and was finally 2.0×10 6 cfu/ml as confirmed by quantitative plate counts.
5 sterile labeled test tubes were used in this experiment, 1ml of TMP diluted solutions in 5 concentration and 1ml of 2×MIC Flos Lonicerae was added in all tubes separately, another 2 sterile tubes were used as extract and media sterility controls, respectively. The final concentration of bacteria in the assay was 1×10 5 cfu/ml. An aliquot of 0.1ml of inoculum cultured broth (2.0×10 6 cfu/ml) was added to each tube. Then the final solutions were incubated at 37°C for 1, 2, 4 and 8h, separately. Samples were plated onto LB agar plates to obtain viable colony counts and calculated bactericidal rate using the formula below:
Bactericidal rate= (control counts-drug control counts)/ control counts×100% Experiments were performed in triplicates.
Statistical analysis
All data were expressed as the mean ± SD. Comparison between groups was performed using ANOVA with post hoc correction for multiple comparisons using Prism software version 4.0c (Graphpad Software, Inc., San Diego, CA). Two-tailed Student t-test was used for other comparisons. The variance at the 0.05 level was considered as significance (P<0.05).
Results
Antimicrobial activity of the combination of Flos Lonicerae with TMP
The antimicrobial activities of Flos Lonicerae and TMP against three indicator strains were shown in Table 1 . The results showed that Flos Lonicerae and TMP had antibacterial activity against Staphylococcus aureus，Escherichia coli and Salmonella, the antibacterial activity against Escherichia coli at a much higher concentration (250mg/ml and 160μg/ml). In checkerboard assay, 62.5mg/ml of Flos Lonicerae combine with 20μg/ml of TMP (Fractional Inhibitory Concentration, FIC index= 0.75) showed additive action against Staphylococcus aureus and Salmonella. The remaining combinations showed additive effect in the checkerboard assay. 
Evaluation of synergy effect in vitro of antibacterial action over different time intervals
Flos Lonicerae and different TMP diluted solutions were chosen for time-kill plot studies. Of these, Flos Lonicerae had an increased bactericidal efficacy on Staphylococcus aureus, Escherichia coli and Salmonella with time increased when they were administered in combination with TMP as shown in Figure   Preprints (www.preprints.org) 
Discussions
In this study, the MICs of the traditional Chinese herbal medicines were detected. Although a considerable variety of plants showing an antimicrobial activity, variation of MIC still exists due to the bioassay methods employed in different studies, the sources and age of the plants, the solvent used for extraction, and strains. Results of our experiments suggested the substance responsible for the antimicrobial properties of Flos Lonicerae was produced within the area of the flower buds [8] . Furthermore, the strength of the inhibitor appears of increase over time. There are several possible explanations for the observed increase in the strength of the inhibitor. Plant material is biologically active and may undergo a variety of the biochemical changes in the postharvest period. Thus, the observed increase in inhibitor strength may be the result of an increased production of the inhibitor or the breakdown of some inhibition repressor. Alternatively, desiccation of stored material may play a part role in the observed increase of the strength of the inhibitor. Flos Lonicerae fruits loose water rapidly after harvest and continue to decline in water content during storage. Herein, the relative amount of the inhibitor may remain constant, but its specific activity may increase with a concomitant reduction in the water content of the flower buds.
When testing the activity of antimicrobial compounds in vitro it is important to use standardized conditions that allow meaningful assessments. In this way, the activity of a given compound against different microorganisms or of different compounds against the same microorganism can be compared. For this reason, there are accepted guidelines to measure the in vitro activity of classical antibiotics, since guidelines for the microamount chessboard dilution method [9] . The susceptibility of Staphylococcus aureus, Escherichia coli and Salmonella to water extracts of Flos Lonicerae was examined and screened in this study with broth dilution diffusion, a quantitative assay method, which is less time-consuming and less labor-intensive than agar dilution method, and cheaper than E test [10] . Both selected herbal medicines are the commonly used traditional Chinese herbal medicines prescribed by physicians of traditional Chinese medicine [11] [12] [13] Flos Lonicerae is even recommended as a dietetic therapy for health preserving. More importantly, both of the selected herbal medicines have a same standard from the Furuibang Corporation, which provided the herbs in this study. The susceptibilities of two isolated Staphylococcus aureus, Escherichia coli and Salmonella strains to Flos Lonicerae were tested in this study. Previous studies as well have described the effect of Flos Lonicerae against Staphylococcus aureus [14] and Escherichia coli. The results of this study demonstrated the inhibitory effect of Flos Lonicerae-TMP against Staphylococcus aureus and Escherichia coli for the first time. In this study, the inhibitory effect of Flos Lonicerae-TMP had a stronger anti-Staphylococcus aureus, anti-Escherichia coli and anti-Salmonella activity than alone, indicating that the compound can be used as useful sources for the synthesis of novel drugs against Staphylococcus aureus, Escherichia coli and Salmonella strains.
Traditional Chinese medicines have a long history, due to their effectiveness and relatively low toxicity, and herbal medicines have drawn more and more attention during the last decade [15, 16] Chemical compositions of Flos Lonicerae has been extensively studied. In our study, water extracts from the medicinal plants demonstrated a strong anti-Staphylococcus aureus and anti-Salmonella strains activity, and a wide range of phytochemistry materials from medicinal plants could reduce the inflammatory response, indicating that the two herbal drugs can be used as anti-inflammatory or antibacterial agents. The strong in vitro anti-Staphylococcus aureus and anti-Salmonella activity of these water extracts does not necessarily imply that they have a strong in vivo anti-Staphylococcus aureus and anti-Salmonella activity. On the other hand, some parts of the two plants may be more potent in vivo due to metabolic transformation of their components into highly active intermediates. Studies of effectiveness of Flos Lonicerae on diseases due to Staphylococcus aureus and Salmonella in the animal model could help resolve this question.
It is exciting that Flos Lonicerae-TMP with a strong anti-Staphylococcus aureus, anti-Escherichia coli and anti-Salmonella activity may provide the potential sources of new drugs, thus reducing the morbidity of diseases and improving the eradication rate and relapse of Staphylococcus aureus, Escherichia coli and Salmonella infection. 
